Australia markets closed

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
1.9100.000 (0.00%)
At close: 03:53PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 479.66M
Enterprise value 84.21M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.58
Enterprise value/revenue N/A
Enterprise value/EBITDA -1.04

Trading information

Stock price history

Beta (5Y monthly) -0.45
52-week change 3-58.48%
S&P500 52-week change 326.24%
52-week high 34.850
52-week low 31.790
50-day moving average 32.065
200-day moving average 32.847

Share statistics

Avg vol (3-month) 340.97k
Avg vol (10-day) 37.62k
Shares outstanding 5243.42M
Implied shares outstanding 6251.13M
Float 881.08M
% held by insiders 172.54%
% held by institutions 116.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-11.44%
Return on equity (ttm)-22.36%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -148.13M
Net income avi to common (ttm)-175.89M
Diluted EPS (ttm)-0.770
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)369.44M
Total cash per share (mrq)1.52
Total debt (mrq)1.76M
Total debt/equity (mrq)0.23%
Current ratio (mrq)20.35
Book value per share (mrq)3.08

Cash flow statement

Operating cash flow (ttm)-49.03M
Levered free cash flow (ttm)-3.8M